Quantcast
issue
Read articles, including Science News stories written for ages 9-14, on the SNK website.
BPA: EPA hasn’t identified a safer alternative for thermal paper
But it’s currently looking for one among 18 candidates
A+ A- Text Size

But it’s currently looking for one among 18 candidates

By Janet Raloff

Web edition: November 16, 2010

Enlarge
BPA and some stand-ins
Here are structural representations of BPA (top) and five structurally related alternatives for use in thermal paper. Moving downward, they are: BPF; BPS; a related sulfone known as TGSA; 2,4-bis; and BPC.
EPA/DfE

Since mid-summer, concerns about exposure to bisphenol A — a hormonelike pollutant — have focused on store receipts. Some researchers and public interest groups have been arguing that BPAfree paper is a preferable alternative, at least from a health perspective. But is it really?

That’s what Environmental Protection Agency scientists want to know. And to date, they maintain, the jury’s still out.

A significant share of the thermal paper used to print store and gas-pump receipts in North America and Europe relies on a color-change chemistry that employs BPA. The leading manufacturer of thermal receipt papers in the United States doesn’t — and on November 8 announced it had begun adding tiny red fibers to its BPAfree receipt-paper stock so that consumers could at a glance identify receipts that wouldn’t shed the controversial chemical.

When I spoke with Appleton Paper’s vice president Kent Willetts about its BPA alternative this past summer, he identified it as bisphenol sulfonate. Last week, I queried the company again about this and its spokesman described the compound as diphenyl sulfone, which he noted is also known as BPS — short for bisphenol S. According to EPA, that BPS actually should be referred to as 4-hydroxyphenyl sulfone.

What’s really at issue, though, is not its name but the chemical’s safety. After all, Appleton switched away from BPA, Willetts says, when a flurry of research papers began pointing to its hormonal alter ego. His company’s scientists reviewed the safety data available for a host of potential substitutes and decided BPS would do the job without carrying the same toxicological baggage.

Moreover, he noted, “the Design for the Environment working group, which we’re part of with the EPA, knows what our substitute is. In fact, it’s on [the group’s] list of alternatives.”

Willetts was referring to an EPA program that has been developing voluntary partnerships between the agency and manufacturers, stores, public interest groups and more to identify and adopt greener alternatives to constituents in consumer products. Earlier this year, EPA added BPA-laced thermal receipt papers to this program.

The alternative that Appleton has chosen is among 18 substitutes for thermal paper that EPA’s DfE program is evaluating in terms of toxicity and environmental persistence. A baker’s dozen of those candidates are already being used in thermal paper somewhere around the world. But it would be unfair to characterize DfE as having selected any as winners, according to Cal Baier-Anderson, EPA’s contact for the program.

“Indeed,” she volunteers, “we have no opinion on the alternatives that we’ve identified because we haven’t completed our analysis yet.” When her program does, it will mark “the first systematic evaluation of the hazard profiles of chemicals that can substitute for BPA in thermal paper,” Baier-Anderson notes. Until then, she emphasizes, any chemical’s appearance on the list of alternatives should not be interpreted as an endorsement or a suggestion of its safety.

The program’s goal is to identify perhaps a handful of low-cost, readily available, nontoxic chemicals that work as well or better than BPA for thermal printing. In fact, that’s probably a pipe dream. “It’s unlikely that EPA is going to come out with the list of preferred chemicals,” Baier-Anderson says, because hazard assessments like this one usually identify nothing more than a list of tradeoffs.

For instance, she offers, “one alternative may not be a reproductive toxicant but it may be an acute aquatic toxicant.” In such instances, EPA may simply leave it to each manufacturer to select its own less-than-perfect stand-in for BPA.

And when can people expect to see the program’s assessment of the candidates? Right now the goal is May 2011, with a formal comparison of the candidate chemicals available for public distribution around October.

Comment
Print Friendly and PDF

Comments (4)

Please alert Science News to any inappropriate posts by clicking the REPORT SPAM link within the post. Comments will be reviewed before posting.

  • Janet, the response we're seeing to BPA is unfortunately typical: Oh, BPA is a problem, so let's switch to BPS, even though not all of the toxicological data is in on it. This kind of thinking seems to me to be lawyer-/litigation-driven rather than science-driven. BPA is "the devil we know", so it would seem to me, absent an incredibly urgent reason to abandon it immediately, that we should stick with BPA until a safe alternative (though it may not be a perfect alternative) has been identified.

    What are your thoughts on that? What are the thoughts of the industry in general on that?
    Robert Woodman Robert Woodman
    Nov. 17, 2010 at 12:10am
  • You ask a difficult question: Switch away from a compound that can induce undesirable biological changes--but usually subtle ones--to another chemical for which few data are in, or stay the course? We'd all like to have good comparison data to contrast the benefits against possible risks. But there hasn't been much motivation to develop those data...until some problems initially begin to turn up. Which was how toxicological interest in BPA slowly emerged, beginning back in the early '90s.

    I think the real issue is why don't we have more tox data to sift through? Why do we assume ingesting non-nutritive substances, such as building blocks of plastics, will necessarily be benign? Shouldn't we see if products we handle have the potential to migrate through skin?

    These are questions that manufacturers and developers of new chemicals have been loath to ask, much less research. And that, I think, is the underlying problem.

    But then I'm biased: I almost always think more research is better--provided it's well-designed, objective and targeted testing aimed at yielding statistically useful data.
    jar jar
    Nov. 17, 2010 at 11:04am
  • Janet, as a practicing scientist, I can never fault the decision to seek more research. That's my natural bent! :-) On the other hand, I work in industry, not academia, and making money for the company is an absolute necessity. When that requirement gets added into the equation, then the decision about whether or not to conduct more research or to switch a new, less-well-researched product becomes more difficult. Liability issues have to be considered as well as product performance and cost effectiveness. Also, if the new product has a learning curve when incorporating it into an existing product, that needs to be considered.

    In a business context, this decision to keep the product, conduct more research, or switch will be more difficult to make, and every decision can be second-guessed and criticized.
    Robert Woodman Robert Woodman
    Nov. 18, 2010 at 5:29am
  • I hear ya...but I also think we should as a society subscribe to the precautionary principle in science as we do in our personal lives (by buying car, home and life insurance). And that's how I see tox analyses of compounds likely to enter our lives in a big way.
    jar jar
    Nov. 18, 2010 at 1:03pm
Registered readers are invited to post a comment. To encourage fruitful discussion, please keep your comments relevant, brief and courteous. Offensive, irrelevant, nonsensical and commercial posts will not be published. (All links will be removed from comments.)

You must register with Science News to add a comment. To log-in click here. To register as a new user, follow this link.

Follow Us